SCHEMBL12694944

SCHEMBL12694944

O=C1Oc2ccccc2/C1=C\c1cc(Cl)c(O)c(Cl)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 3/20 0.74
▸ TOP2A P11388 1/20 0.74
▸ SIRT1 Q96EB6 2/20 0.53
▸ SIRT2 Q8IXJ6 1/20 0.53
▸ SIRT5 Q9NXA8 1/20 0.53
▸ LCK P06239 4/20 0.48
▸ PRKACA P17612 2/20 0.48
▸ SRC P12931 1/20 0.48
▸ PRKACG P22612 1/20 0.48
▸ PRKACB P22694 1/20 0.48
▸ RAF1 P04049 1/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.47
▸ MCL1 Q07820 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ STK17B O94768 3/20 0.44
▸ MIF P14174 1/20 0.44
▸ HDAC3 O15379 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4261091 0.83 TOP1 (0.75) TOP1TOP2ALCKPRKACAMEN1
SCHEMBL4261090 0.83 TOP1 (0.75) TOP1TOP2ALCKPRKACAMEN1
SCHEMBL12694945 0.82 TOP1 (0.74) TOP1TOP2ASIRT1SIRT2SIRT5
SCHEMBL12694949 0.81 STK17B (0.66) PRKACAMEN1KMT2ASTK17BHDAC3
SCHEMBL4267528 0.78 TOP1 (0.76) TOP1TOP2ALCKPRKACAMEN1
SCHEMBL4267530 0.78 TOP1 (0.76) TOP1TOP2ALCKPRKACAMEN1
SCHEMBL1078524 0.77 TOP1 (0.66) TOP1TOP2AMEN1KMT2AALDH1A1
SCHEMBL5082831 0.72 RAF1 (0.73) RAF1EGFRIGF1RKDRPLK1
SCHEMBL4727806 0.72 RAF1 (0.73) RAF1EGFRIGF1RKDRPLK1
SCHEMBL30429323 0.72 TOP1 (0.59) TOP1TOP2AMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9567305-B2 Quinoxaline compounds and derivatives SOUTHERN METHODIST UNIVERSITY (US) 2017-02-14 — — US disclosed
US-9567305-B2 Quinoxaline compounds and derivatives SOUTHERN METHODIST UNIVERSITY (US) 2017-02-14 — — US disclosed
US-20140135494-A1 Quinoxaline Compounds and Derivatives SOUTHERN METHODIST UNIVERSITY (US) 2014-05-15 — — US disclosed
US-20140135494-A1 Quinoxaline Compounds and Derivatives SOUTHERN METHODIST UNIVERSITY (US) 2014-05-15 — — US disclosed
US-8669363-B2 Quinoxaline compounds and derivatives SOUTHERN METHODIST UNIVERSITY (US) 2014-03-11 — — US disclosed
US-8669363-B2 Quinoxaline compounds and derivatives SOUTHERN METHODIST UNIVERSITY (US) 2014-03-11 — — US disclosed
US-20120245352-A1 Quinoxaline Compounds and Derivatives SOUTHERN METHODIST UNIVERSITY (US) 2012-09-27 — — US disclosed
US-20120245352-A1 Quinoxaline Compounds and Derivatives SOUTHERN METHODIST UNIVERSITY (US) 2012-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140135494-A1 Quinoxaline Compounds and Derivatives CYP3A5, PDXK, QDPR TOP1 63/4885TOP2A 55/4885SIRT1 167/4885
US-20120245352-A1 Quinoxaline Compounds and Derivatives CYP3A5, PDXK, QDPR TOP1 63/4885TOP2A 55/4885SIRT1 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback